Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting

Inclusion Criteria:

* Patients must have the ability to understand and sign a written informed consent document, and be willing to follow protocol requirements
* Ability to read and understand English for patient reported outcomes
* Age \>= 18 years
* Eastern Cooperative Oncology Group (ECOG) performance status =\< 2
* Willingness to comply with all study interventions of essential oil aromatherapy
* Have been on a moderate- to high-risk emetogenic chemotherapy regimen as defined by the National Comprehensive Cancer Network (NCCN) for at least 1 cycle of therapy
* At least 2 remaining infusion appointments on a moderate- to high-risk emetogenic chemotherapy regimen as defined by the NCCN
* Have nausea defined as \> 3/10 with last chemotherapy infusion based on screening symptom questionnaire
* The study is open to all participants regardless of gender, race, or ethnicity

Exclusion Criteria:

* Self-reported aversion or sensitivity to lavender oil, peppermint oil, ginger oil, jojoba oil
* Uncontrolled respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD)
* Mental incapacitation (ex. stroke, brain metastasis etc.) that would cause inability to follow directions, in the opinion of the investigators
* Ongoing uncontrolled active psychiatric condition that would interfere in the conduct of the study (e.g., mood disorders, anxiety, psychosis disorders, or substance use)
* Self-reported abnormal smelling abilities (for ex: ongoing sinus infections, long covid, etc.)
* Aromatherapy use in the last 30 days